Moderna has filed for emergency-use authorization from the US Food and Drug Administration for its COVID-19 vaccine to be used in adolescents ages 12 to 17. If approved, it would be the second vaccine approved for that age group.
Moderna has filed for emergency-use authorization from the US Food and Drug Administration for its COVID-19 vaccine to be used in adolescents ages 12 to 17. If approved, it would be the second vaccine approved for that age group.
No comments:
Post a Comment